<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01953380</url>
  </required_header>
  <id_info>
    <org_study_id>ISICA-13</org_study_id>
    <nct_id>NCT01953380</nct_id>
  </id_info>
  <brief_title>Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy</brief_title>
  <acronym>ISICA-13</acronym>
  <official_title>Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether extended information given to patients with
      contact allergy improves knowledge, treatment efficacy and daily functioning.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>knowledge</measure>
    <time_frame>one year after inclusion</time_frame>
    <description>knowledge about specific contact allergies and exposure, assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and patient records.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical improvement</measure>
    <time_frame>one year after inclusion</time_frame>
    <description>assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and patient records.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>one year after inclusion</time_frame>
    <description>assessed by questionnaire, Dermatology Life Quality Index (DLQI).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>effect on daily functioning</measure>
    <time_frame>one year after inclusion</time_frame>
    <description>assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and Dermatology Life Quality Index (DLQI).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">400</enrollment>
  <condition>Dermatitis, Allergic Contact</condition>
  <arm_group>
    <arm_group_label>extended information</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Extended information on specific allergy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Information according to clin. routine</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Information according to clinical routine</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>extended information</intervention_name>
    <arm_group_label>extended information</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with suspected contact allergy

          -  Age above 18 years

          -  Participants have given informed consent

        Exclusion Criteria:

          -  Mental or language disabilities
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Sonesson, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Region Skåne, Hudkliniken SUS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hudmottagningen SUS</name>
      <address>
        <city>Lund</city>
        <state>Skåne</state>
        <zip>22185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2013</study_first_submitted>
  <study_first_submitted_qc>September 24, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2013</study_first_posted>
  <last_update_submitted>April 11, 2017</last_update_submitted>
  <last_update_submitted_qc>April 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Region Skane</investigator_affiliation>
    <investigator_full_name>Andreas Sonesson</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>Intervention Studies</keyword>
  <keyword>Eczema</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <keyword>Knowledge</keyword>
  <keyword>Quality of Life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Allergic Contact</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

